How to Buy Nektar Therapeutics Stock

Nektar Therapeutics

Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally.

Nektar Therapeutics stock last closed at $84.16, down 3.14% from the previous day, and has increased 716.45% in one year. It has overperformed other stocks in the Biotechnology industry by 7.34 percentage points. Nektar Therapeutics stock is currently +953.32% from its 52-week low of $7.99, and -22.79% from its 52-week high of $109.00.

There are currently 28.69M NKTR shares outstanding. The market capitalization of NKTR is $2.41B. In the past 24 hours, 797,000 NKTR shares were traded.

How to Buy Nektar Therapeutics Stock

Not sure how to invest in Nektar Therapeutics stock? Here's how.

  1. Decide where to buy Nektar Therapeutics stock: You need to pick a stock brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you choose where to buy Nektar Therapeutics stock.
  2. Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
  3. Deposit money your investment account: Pick your method of payment and add your info.
  4. Evaluate Nektar Therapeutics stock: The Nektar Therapeutics ticker symbol is NKTR. Is Nektar Therapeutics stock a good investment? Should you buy shares of NKTR? How do NKTR's underlying business fundamentals look? Do top analysts think Nektar Therapeutics is a good buy? Why has NKTR's stock price moved recently? (Hint: Our stock market analysis website can help you figure out if NKTR is a good stock to buy).
  5. Execute your NKTR buy order: Decide if you will purchase NKTR shares at the current market price or use a limit order to buy NKTR shares at a specific price.
  6. Get notifications regarding your NKTR investment: Create a watchlist to track your new investment in Nektar Therapeutics shares.

Step 1: Decide where to buy Nektar Therapeutics stock

You need a brokerage account in order to access the NASDAQ market and buy NKTR stock.

A brokerage account is an investment account that enables you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

Based on our research, eToro is the best brokerage. Here's why:

  • Invest in stocks with zero commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
  • Access to global financial markets: From Technology to Utilities, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
  • Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your stock purchase by opening an account with eToro today. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open your brokerage account

Now that you've chosen the right brokerage, you need to fill out some personal info so you can buy NKTR today.

How to Create a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Enter your personal data to create your new trading account.
  1. Submit your info by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit money your investment account

Now that you have opened your account on the best beginner stock app, you need to deposit funds:

Watch the video below for more details depositing money into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Evaluate Nektar Therapeutics stock

Once you have decided on the best place to buy Nektar Therapeutics stock, it's important to evaluate their stock before you invest, so you can wrap your head around the risk as well as the upside.

Nektar Therapeutics quick stats

NKTR Price
$84.16
1w %
0.42%
1y %
716.45%
5y %
-69.96%
P/E
N/A
P/B
26.88x
P/S
200.38x
PEG
N/A
Revenue
$12.04M
Earnings
-$209.19M
Fore. Rev. Growth
54.88%
Fore. Earn. Growth
N/A
Market Cap
$2.41B
Next Earnings
N/A
Next Dividend
N/A

Nektar Therapeutics Due Diligence Checks

WallStreetZen was built to help average investors perform more in-depth fundamental analysis quickly.

You can view all of the due diligence checks on NKTR's stock page.

Is NKTR stock properly valued?

Investors use a variety of different financial metrics, analyses, models, and charts to gauge NKTR's true value.

Using relative valuations measures:

  • NKTR may be overvalued based on its P/B ratio of 26.88x, relative to Biotechnology industry P/B ratio of 5.01x

You can do additional valuation analysis on NKTR's stock here.

NKTR Financial Summary

Positive Health Checks:

  • There are more short-term assets than long-term liabilities on the NKTR balance sheet.
  • There are more short-term assets than short-term liabilities on the NKTR balance sheet.
  • NKTR has $245.75M in cash and short term investments. This is enough to cover its annual cash burn of $209.38M.
  • NKTR has cash burn of 209379000. It has sufficient cash and short-term investments to cover this for at least one year.

Negative Health Checks:

  • Total NKTR debt is higher than 5 years ago, relative to shareholder equity.
  • NKTR has a relatively high debt to equity ratio of 2.12.
  • NKTR profit margin has gone down from -120.9% to -1,737.9% in the past year.

Do Wall Street analysts think it's a good time to buy NKTR stock

Out of 6 Equities analysts who monitor NKTR, the consensus analyst rating on Nektar Therapeutics is a Strong Buy

Please note that analyst forecasts are not recommendations, nor are they financial advice.

Most Recent NKTR Analyst Recommendations

Roger Song, a top 19% analyst from Jefferies maintains NKTR with a strong buy rating and raises their NKTR price target from $99.00 to $121.00, on Nov 26, 2025.

Jefferies's Roger Song raised their price target on Nektar Therapeutics (NASDAQ: NKTR) by 22.2% from $99 to $121 on 2025/11/26. The analyst maintained their Strong Buy rating on the stock.

Saying they are previewing  Nektar Therapeutics' report of Rezpeg Phase 2b topline data in Alopecia Areata next month with "relatively low expectations," Song said "significant upside potential and limited downside" are visible because of Rezpeg's novel mechanism of action, clean safety profile, and durability potential.

The analyst noted that they added AA to their Nektar Therapeutics model at 20% odds of success and $300M in peak sales potential.

You can dive deeper into what analysts are projecting on the Nektar Therapeutics stock forecast page.

NKTR Momentum

SMA10
87.24
SMA20
85.76
SMA50
77.3
SMA100
61.98
SMA200
54.37
MACD
2.91
MACD Signal
4
MACD Histogram
-1.1
RSI
52.03
Stochastic %K
20.69
Stochastic %D
23.24
StochRSI %K
10.48
StochRSI %D
10.31

NKTR Performance Metrics

Last year, NKTR revenue was $12.04M. During the past five year, NKTR's revenue has grown by -39.85% per year. This was slower than the Biotechnology industry average of 26.41%.

Find out more about NKTR's earnings and revenue performance here.

What are NKTR insiders up to?

In the last year, insiders at NKTR have sold more shares than they have bought.

Howard W. Robin, President CEO of NKTR, was the latest NKTR insider to sell. They sold $30,879.00 worth of NKTR stock on Feb 18, 2026.

Dig into more about who owns NKTR shares here.

Does NKTR stock generate passive income?

No, Nektar Therapeutics doesn't provide an income stream by paying out dividends.

What others are saying about NKTR

One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.

Click below to find out what other community members have to say.

Step 5: Execute your NKTR buy order

You have two primary types of orders:

  • Market order: A market order is an order to buy or sell a stock at the best possible price.
    Market orders are usually the best for newer investors.
  • Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
    If you want to ensure you're buying or selling at a specific dollar amount limit, place a limit order.

Click the Open Trade button and your broker will execute the order.

If you want more help with investing in stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Get notifications regarding your NKTR investment

Now that you own some NKTR shares, you'll want to keep up with your investment.

Put NKTR on a watchlist to get the latest updates about your NKTR stock.

NKTR Feed

How to Buy Stock in Nektar Therapeutics

To reiterate, here are the 6 steps to buy stock in Nektar Therapeutics:

  1. Decide where to buy Nektar Therapeutics stock
  2. Open your brokerage account
  3. Deposit money your investment account
  4. Evaluate Nektar Therapeutics stock
  5. Execute your NKTR buy order
  6. Get notifications regarding your NKTR investment

If you require a place to buy stocks, eToro is our recommended venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to track your investment in Nektar Therapeutics, create your watchlist below.

NASDAQ: NKTR
$84.16-2.73 (-3.14%)
Updated May 5, 2026
Open eToro Account
Your capital is at risk.
NASDAQ: NKTR
$84.16-2.73 (-3.14%)
Updated May 5, 2026
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Nektar Therapeutics share?

As of May 5, 2026, it costs $84.16 to buy one share of Nektar Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.119 shares of NKTR.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Nektar Therapeutics stock?

According to 6 Wall Street analysts who monitor Nektar Therapeutics, their consensus recommendation is to buy Nektar Therapeutics stock.

What is the best way to buy Nektar Therapeutics stock?

One way to place an order for Nektar Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.